Twist Bioscience Corporation (NASDAQ:TWST), a synthetic DNA specialist with a market capitalization of $2.8 billion, recently held its Annual Meeting of Stockholders, resulting in significant ...

On Tuesday, the company's stockholders approved an amendment to the Certificate of Incorporation, which now includes exculpation provisions for certain officers as permitted by Delaware law.